Drugs that contain Propranolol Hydrochloride
1. List of Hemangeol drug patents
HEMANGEOL's oppositions filed in EPO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8338489 | PIERRE FABRE DERMA | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
Oct, 2028
(5 years from now) | |
| US8987262 | PIERRE FABRE DERMA | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
Oct, 2028
(5 years from now) | |
Market Authorisation Date: 14 March, 2014
Treatment: Method to treat hemangioma.; Method to treat infantile hemangioma
Dosage: SOLUTION;ORAL
How can I launch a generic of HEMANGEOL before it's patent expiration?
More Information on Dosage
HEMANGEOL family patents
7
United States
3
European Union
2
Denmark
2
Hong Kong
2
Slovenia
2
Croatia
2
Portugal
2
Cyprus
2
Spain
2
Korea, Republic of
2
Poland
2
China
1
Israel
1
IB
1
Austria
1
Mexico
1
Australia
1
Saudi Arabia
1
Russia
1
Morocco
1
Germany
1
Argentina
1
Colombia
1
Brazil
1
Malaysia
1
Chile
1
Taiwan, Province of China
1
Japan
1
Canada
1
Tunisia
1
Panama
1
New Zealand
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic